[1] |
ZHANG Yong-Qing, WANG Rui, ZHU Man, ZHANG Jian-Peng, ZHANG Yong-Mei, TONG Jun.
Observation of morphology in Escherichia coli with atom microscope during the cefmetazole-induced post-antibiotic effect period
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(10): 1123-1127.
|
[2] |
LIU Zhen-Tong, GU Jun-Ming.
Clinical study of low dose continuous infusion of ceftazidime (CAZ) for the treatment of low respiratory tract infections
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2000, 5(3): 235-237.
|
[3] |
.
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2000, 5(1): 13-13.
|
[4] |
.
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1998, 3(1): 77-77.
|
[5] |
.
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1997, 2(4): 299-301.
|
[6] |
Liang Yuxia1, Chen Qian, Wang Rui, Fang Yi, Liu Qingfeng.
Study on features of postantibiotic effects induced by six β-Lactams against Gram-negative bacilli
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1997, 2(3): 186-189.
|
[7] |
Wang Liyu, Hua Jinhui, Wang Guihua, Wang Tiesheng, Wang Youcai, Chen Liru.
Clinical trial of mezlocillin in treatment of gonorrheae
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1997, 2(3): 199-200.
|
[8] |
Wang Rui, Chen Qian, Chen Mengli, Lou Fangding, Zhu Jun, Han Xiaoping, Tan Cie, Pei Baoxiang, Wang Aizhen.
Study on the serum bactericidal activity and clinical effects of cefotaxime in patients with hematopathy and infection complication
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1997, 2(1): 17-19.
|
[9] |
.
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1997, 2(1): 23-23.
|
[10] |
Fang Xiangqun, Liu Youning, Wang Rui, Chen Qian, Li Yong, Che Mengli, Zhao Zhijian.
Study on the antibacterial activity in vitro of cefoperazone/sulbactam
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1996, 1(1): 8-12.
|
[11] |
.
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1996, 1(1): 60-60.
|